Reaction Details |
| Report a problem with these data |
Target | Plasminogen activator inhibitor 1 |
---|
Ligand | BDBM50139534 |
---|
Substrate/Competitor | n/a |
---|
Meas. Tech. | ChEBML_155740 |
---|
IC50 | 500±n/a nM |
---|
Citation | Ye, B; Chou, YL; Karanjawala, R; Lee, W; Lu, SF; Shaw, KJ; Jones, S; Lentz, D; Liang, A; Tseng, JL; Wu, Q; Zhao, Z Synthesis and biological evaluation of piperazine-based derivatives as inhibitors of plasminogen activator inhibitor-1 (PAI-1). Bioorg Med Chem Lett14:761-5 (2004) [PubMed] |
---|
More Info.: | Get all data from this article, Assay Method |
---|
|
Plasminogen activator inhibitor 1 |
---|
Name: | Plasminogen activator inhibitor 1 |
Synonyms: | Endothelial plasminogen activator inhibitor | PAI | PAI-1 | PAI1 | PAI1_HUMAN | PLANH1 | Plasminogen activator inhibitor 1 | Plasminogen activator inhibitor 1 (PAI-1) | Plasminogen activator inhibitor-1 | Plasminogen activator-1 (PAI-1) | SERPINE1 |
Type: | Enzyme |
Mol. Mass.: | 45064.00 |
Organism: | Homo sapiens (Human) |
Description: | P05121 |
Residue: | 402 |
Sequence: | MQMSPALTCLVLGLALVFGEGSAVHHPPSYVAHLASDFGVRVFQQVAQASKDRNVVFSPY
GVASVLAMLQLTTGGETQQQIQAAMGFKIDDKGMAPALRHLYKELMGPWNKDEISTTDAI
FVQRDLKLVQGFMPHFFRLFRSTVKQVDFSEVERARFIINDWVKTHTKGMISNLLGKGAV
DQLTRLVLVNALYFNGQWKTPFPDSSTHRRLFHKSDGSTVSVPMMAQTNKFNYTEFTTPD
GHYYDILELPYHGDTLSMFIAAPYEKEVPLSALTNILSAQLISHWKGNMTRLPRLLVLPK
FSLETEVDLRKPLENLGMTDMFRQFQADFTSLSDQEPLHVAQALQKVKIEVNESGTVASS
STAVIVSARMAPEEIIMDRPFLFVVRHNPTGTVLFMGQVMEP
|
|
|
BDBM50139534 |
---|
n/a |
---|
Name | BDBM50139534 |
Synonyms: | 2-[2-Methoxy-6-({3-trifluoromethyl-4-[4-(3-trifluoromethyl-phenyl)-piperazin-1-yl]-phenylamino}-methyl)-phenoxy]-5-nitro-benzoic acid | CHEMBL349130 |
Type | Small organic molecule |
Emp. Form. | C33H28F6N4O6 |
Mol. Mass. | 690.589 |
SMILES | COc1cccc(CNc2ccc(N3CCN(CC3)c3cccc(c3)C(F)(F)F)c(c2)C(F)(F)F)c1Oc1ccc(cc1C(O)=O)[N+]([O-])=O |
Structure |
|